Phase II Study of Reduced Intensity Conditioning With Busulfan/Clofarabine Followed by Allogeneic Stem Cell Transplantation
Phase of Trial: Phase II
Latest Information Update: 15 Jul 2017
At a glance
- Drugs Busulfan (Primary) ; Clofarabine (Primary) ; Anti-infectives; Filgrastim; Methotrexate; Tacrolimus
- Indications Graft-versus-host disease; Haematological malignancies
- Focus Pharmacodynamics
- 03 Oct 2016 Status changed from active, no longer recruiting to completed.
- 22 Sep 2015 Planned End Date changed from 1 Aug 2015 to 1 Aug 2016 as reported by ClinicalTrials.gov record.
- 22 Sep 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Aug 2016 as reported by ClinicalTrials.gov record.